PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+15.09%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.33B
AUM Growth
+$519M
(+29%)
Cap. Flow
+$284M
Cap. Flow
% of AUM
12.18%
Top 10 Holdings %
Top 10 Hldgs %
31.18%
Holding
1,170
New
202
Increased
753
Reduced
172
Closed
43
Top Buys
| 1 |
Broadcom
AVGO
|
+$15.7M |
| 2 |
Tesla
TSLA
|
+$13.8M |
| 3 |
Microsoft
MSFT
|
+$6.28M |
| 4 |
Apple
AAPL
|
+$5.88M |
| 5 |
NVIDIA
NVDA
|
+$5.68M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$4.04M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.47M |
| 3 |
eBay
EBAY
|
+$1.37M |
| 4 |
Align Technology
ALGN
|
+$1.31M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$1.3M |
Sector Composition
| 1 | Technology | 39.75% |
| 2 | Healthcare | 13.35% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Communication Services | 9.24% |
| 5 | Energy | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
451
DELISTED
Cymabay Therapeutics
CBAY
| $620K | 0.03% |
26,263
+7,302
| +39% | +$172K |
|
452
RELX
RELX
$82.4B
| $615K | 0.03% |
15,507
+84
| +0.5% | +$3.33K |
|
453
GSK
GSK
$81.5B
| $615K | 0.03% |
16,584
+7,149
| +76% | +$265K |
|
454
Noble Corp
NE
$4.82B
| $612K | 0.03% |
12,710
-1,726
| -12% | -$83.1K |
|
455
Elanco Animal Health
ELAN
$9.11B
| $608K | 0.03% |
40,830
-10,590
| -21% | -$158K |
|
456
Keysight
KEYS
$29.3B
| $608K | 0.03% |
3,819
+836
| +28% | +$133K |
|
457
Extra Space Storage
EXR
$30.8B
| $604K | 0.03% |
3,765
+642
| +21% | +$103K |
|
458
ImmunityBio
IBRX
$2.43B
| $602K | 0.03% |
+119,957
| New | +$602K |
|
459
Liberty Energy
LBRT
$1.76B
| $602K | 0.03% |
33,191
-10,873
| -25% | -$197K |
|
460
Tidewater
TDW
$2.97B
| $602K | 0.03% |
8,346
-1,684
| -17% | -$121K |
|
461
Fastly
FSLY
$1.08B
| $598K | 0.03% |
33,623
+5,024
| +18% | +$89.4K |
|
462
MSCI
MSCI
$43.6B
| $598K | 0.03% |
1,058
+153
| +17% | +$86.5K |
|
463
Relay Therapeutics
RLAY
$700M
| $595K | 0.03% |
54,029
-9,902
| -15% | -$109K |
|
464
Oceaneering
OII
$2.45B
| $594K | 0.03% |
27,919
-1,997
| -7% | -$42.5K |
|
465
MetLife
MET
$52.7B
| $593K | 0.03% |
8,972
+1,806
| +25% | +$119K |
|
466
Kinross Gold
KGC
$28B
| $590K | 0.03% |
97,551
+5,390
| +6% | +$32.6K |
|
467
Editas Medicine
EDIT
$230M
| $589K | 0.03% |
58,167
-24,940
| -30% | -$253K |
|
468
Aptiv
APTV
$17.8B
| $589K | 0.03% |
6,560
+884
| +16% | +$79.3K |
|
469
VICI Properties
VICI
$35.3B
| $587K | 0.03% |
18,428
+3,449
| +23% | +$110K |
|
470
Cencora
COR
$57.4B
| $586K | 0.03% |
2,851
+290
| +11% | +$59.6K |
|
471
Geron
GERN
$823M
| $582K | 0.03% |
275,823
-47,034
| -15% | -$99.2K |
|
472
Arcturus Therapeutics
ARCT
$489M
| $581K | 0.03% |
18,424
-3,874
| -17% | -$122K |
|
473
British American Tobacco
BTI
$123B
| $580K | 0.02% |
19,819
+6,574
| +50% | +$193K |
|
474
Fifth Third Bancorp
FITB
$30.1B
| $577K | 0.02% |
16,736
+3,962
| +31% | +$137K |
|
475
Agios Pharmaceuticals
AGIO
$2.07B
| $569K | 0.02% |
25,558
+2,442
| +11% | +$54.4K |
|